The Surgeon's Scorecard: What Subramaniakumar Actually Built
Subramaniakumar’s tenure was a masterclass in balance-sheet de-risking. He inherited a bank that had posted a net loss of ₹74.74 crore in FY22, plagued by corporate loan write-offs and underwriting skittishness.
RBL BANK FINANCIAL METRICS (FY22 – FY26)
----------------------------------------------------------------------
Metric FY22 FY24 (Peak) FY25 (Stress) FY26
----------------------------------------------------------------------
Gross NPA (%) 4.40% 2.65% 1.80% 1.45%
Net Profit (Cr) -₹74.7 Cr ₹1,168 Cr ₹695 Cr ₹822 Cr
Net Worth (Cr) ~₹12,600 Cr ~₹14,500 Cr ~₹15,200 Cr ~₹16,400 Cr
CRAR (%) 16.2% 16.1% 15.8% 15.3%
----------------------------------------------------------------------
Post-Emirates NBD Infusion (June 2026): CRAR surges to >25%; Net Worth reaches >₹42,000 Cr.
By March 2026:
- Asset Quality Restored: Gross NPAs plummeted from 4.40% to 1.45%, outperforming several older private sector peers.
- Return to Sustained Profitability: The bank turned around to post ₹1,168 crore in FY24 profit before navigating the FY25 unsecured lending headwinds with an ₹822 crore profit in FY26.
- Corporate Governance Reinforced: Risk architecture was recalibrated, institutional underwriting tightened, and the regulator's oversight concerns systematically dismantled.
Yet, despite this operational victory, RBL Bank’s board agreed to cede 60% control to Dubai’s largest banking conglomerate.
-1200x675.jpg&w=3840&q=75)

-800x450.jpg&w=3840&q=75)

-800x450.jpg&w=3840&q=75)
-800x450.jpg&w=3840&q=75)
-800x450.jpg&w=3840&q=75)
-800x450.jpg&w=3840&q=75)
-800x450.jpg&w=3840&q=75)